Samir Nasri is reportedly the subject of an anti-doping investigation, after the Manchester City midfielder was rumoured to have received an intravenous drip while visiting an American clinic last week.
A report from Spanish publication El Pais (h/t James Ducker of the Daily Telegraph) reported the anti-doping agency in Spain, known as AEPSAD, has started an investigation.
Ducker spelled out how Nasri, currently on loan at La Liga club Sevilla, may have violated anti-doping laws if he was treated by an IV drip: "Under World Anti-Doping Agency (WADA) rules, only intravenous infusions of up to 50 millilitres are allowed unless there is clear medical reason, such as a hospital admission, or if an athlete has a Therapeutic Use Exemption (TUE).